Litcius/Paper detail

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Maria K. Angelopoulou, Sophia Chatziioannou, Vassilios Prassopoulos, Stamatis Karakatsanis, Maria Arapaki, Zois Mellios, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ιoannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, Evangelos Terpos, Evridiki Michali, George Karianakis, Pantelis Tsirkinidis, Chryssa Vadikolia, Christos Poziopoulos, Anna Pigaditou, Effimia Vrakidou, Marina P. Siakantaris, Marie‐Christine Kyrtsonis, Argiris Symeonidis, Konstantinos Anargyrou, Maria Papaioannou, Evdoxia Chatziharissi, Elissavet Vervessou, Maria Tsirogianni, Maria Palassopoulou, Gabriella Gainaru, Catherine Mainta, Panagiotis Tsirigotis, Theodora Assimakopoulou, Pavlina Konstantinidou, Helen Α. Papadaki, Meletios Α. Dimopoulos, Vassiliki Pappa, Themis Karmiris, Paraskevi Roussou, Ioannis Datseris, Panayiotis Panayiotidis, Kostas Konstantopoulos, Gerassimos A. Pangalis, Phivi Rondogianni

2021Annals of Hematology26 citationsDOI

Topics & Concepts

MedicineRituximabMediastinumNuclear medicineRadiation therapyPositron emission tomographyLymphomaHematologyRadiologyRetrospective cohort studyInternal medicineLymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentCardiac tumors and thrombi